New Drug Pricing Bill from House Democrat Leadership Threatens to Short-Circuit California Biomedical Innovation

New Drug Pricing Bill from House Democrat Leadership Threatens to Short-Circuit California Biomedical Innovation

Play Episode Pause Episode

Mute/Unmute Episode Rewind 10 Seconds 1x Fast Forward 30 seconds

00:00 /

RSS Feed

Share

Link

Embed

WASHINGTON & SAN FRANCISCO & SAN DIEGO–(BUSINESS WIRE)– #DrugPricing–California Life Sciences Association (CLSA) Voices Concerns with Speaker Pelosi?s Drug Pricing Proposal